Jesper Nylandsted Selected Research

Jesper Nylandsted Research Topics

Disease

25	Neoplasms (Cancer) 01/2023 - 12/2002
10	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2002
5	Rupture 02/2024 - 01/2020
5	Wounds and Injuries (Trauma) 01/2021 - 09/2015
2	Prostatic Neoplasms (Prostate Cancer) 07/2016 - 10/2013
2	Carcinoma (Carcinomatosis) 03/2007 - 12/2004
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Parkinson Disease (Parkinson's Disease) 08/2021
1	Dementia (Dementias) 08/2021
1	Hypersensitivity (Allergy) 01/2021
1	Glioma (Gliomas) 11/2016
1	Necrosis 11/2015
1	Niemann-Pick Diseases (Niemann Pick Disease) 01/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2009
1	Ascites 01/2007
1	Brain Ischemia (Cerebral Ischemia) 02/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2003
1	Huntington Disease (Huntington's Disease) 04/2003
1	Disease Progression 04/2003
1	Glioblastoma (Glioblastoma Multiforme) 12/2002

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2002
10	AnnexinsIBA 02/2024 - 01/2015
8	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 02/2009 - 12/2002
5	CathepsinsIBA 11/2016 - 12/2004
4	Phosphotransferases (Kinase)IBA 10/2013 - 12/2004
4	Lu 28-179 (Siramesine)IBA 09/2013 - 03/2007
3	Annexin A2 (Annexin II)IBA 09/2015 - 05/2014
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 10/2013 - 01/2010
3	CaspasesIBA 12/2004 - 12/2002
2	SphingomyelinsIBA 01/2023 - 09/2013
2	PhenothiazinesIBA 01/2023 - 01/2021
2	CalciumIBA 01/2023 - 01/2021
2	Detergents (Detergent)IBA 01/2021 - 05/2008
2	Annexin A4IBA 01/2020 - 11/2017
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 01/2019
2	LipidsIBA 11/2017 - 01/2010
2	AcidsIBA 10/2013 - 09/2013
2	Cysteine (L-Cysteine)FDA Link 03/2012 - 12/2004
2	Small Interfering RNA (siRNA)IBA 01/2012 - 08/2011
2	sigma-2 receptorIBA 05/2008 - 03/2007
2	LigandsIBA 05/2008 - 03/2007
2	Complementary DNA (cDNA)IBA 12/2004 - 12/2002
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	Annexin A5IBA 06/2022
1	GoldIBA 06/2022
1	SynucleinsIBA 08/2021
1	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	IonsIBA 01/2020
1	Endosomal Sorting Complexes Required for TransportIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Annexin A7 (Synexin)IBA 01/2019
1	CeramidesIBA 11/2016
1	dihydroceramideIBA 11/2016
1	Dronabinol (THC)FDA LinkGeneric 11/2016
1	AstemizoleIBA 07/2016
1	ebastine (Kestin)IBA 07/2016
1	Histamine Antagonists (Antihistamines)IBA 07/2016
1	Loratadine (Alavert)FDA Link 07/2016
1	Peptide Hydrolases (Proteases)FDA Link 11/2015
1	S100 Proteins (S 100 Protein)IBA 09/2015
1	Calcium-Binding ProteinsIBA 05/2014
1	SU 11652IBA 10/2013
1	Sunitinib (Sutent)FDA Link 10/2013
1	Protein Kinases (Protein Kinase)IBA 03/2012
1	ZincIBA 03/2012
1	Cathepsin BIBA 03/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2012
1	Protein Kinase C-alphaIBA 03/2012
1	monastrolIBA 01/2012
1	neodymium pyrocatechin disulfonate (NPD)IBA 01/2010
1	Oleic Acid (Oleate)IBA 01/2010
1	Lactalbumin (alpha-Lactalbumin)IBA 01/2010
1	KinesinsIBA 01/2009
1	ProteomeIBA 01/2009
1	AminesIBA 05/2008
1	Vincristine (Oncovin)FDA LinkGeneric 03/2007
1	Antimitotic AgentsIBA 03/2007
1	cariporideIBA 01/2007
1	Mitogen-Activated Protein KinasesIBA 01/2007
1	ethylisopropylamiloride (EIPA)IBA 01/2007
1	Green Fluorescent ProteinsIBA 12/2004
1	Histones (Histone)IBA 12/2004
1	Etoposide (VP 16)FDA LinkGeneric 12/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004
1	Indicators and Reagents (Reagents)IBA 02/2004
1	polyglutamineIBA 04/2003

Therapy/Procedure

7	Therapeutics 01/2023 - 03/2005
3	Drug Therapy (Chemotherapy) 01/2023 - 10/2013
3	Lasers (Laser) 06/2022 - 02/2004